Altus out, Ellis in as CEO at ImpactRx
Ellis is a former IRI executive and has also previously worked for Nielsen and Opinion Research Corporation. He was most recently a senior partner at digital marketing agency Rosetta, where he worked with pharmaceutical brands on patient and physician segmentations.
Rosetta was bought by Publicis Groupe in May.
ImpactRX maintains panels of physicians to monitor the effect that product promotions have on their prescribing behaviour. Symphony Technology Group bought a majority stake in the business in April, and the business is also part-owned by the drug company Merck.

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments